Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-02-27 @ 7:05 PM
Study NCT ID:
NCT00467051
Status:
COMPLETED
Last Update Posted:
2018-08-29
First Post:
2007-04-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
Sponsor:
Children's Oncology Group
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Childhood Extracranial Germ Cell Tumor | View |
| None | Childhood Extragonadal Malignant Germ Cell Tumor | View |
| None | Childhood Malignant Ovarian Germ Cell Tumor | View |
| None | Childhood Malignant Testicular Germ Cell Tumor | View |
| None | Ovarian Choriocarcinoma | View |
| None | Ovarian Embryonal Carcinoma | View |
| None | Ovarian Yolk Sac Tumor | View |
| None | Recurrent Childhood Malignant Germ Cell Tumor | View |
| None | Recurrent Malignant Testicular Germ Cell Tumor | View |
| None | Recurrent Ovarian Germ Cell Tumor | View |
| None | Testicular Choriocarcinoma | View |
| None | Testicular Embryonal Carcinoma | View |
| None | Testicular Mixed Choriocarcinoma and Embryonal Carcinoma | View |
| None | Testicular Mixed Choriocarcinoma and Yolk Sac Tumor | View |
| None | Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor | View |
| None | Testicular Yolk Sac Tumor | View |
Keywords: